Brief: Acumen Pharmaceuticals, Inc. FY Income From Operations USD -114.017 Million

Acumen Pharmaceuticals

27/03/2025 11:00

Mar 27 (Reuters) - Acumen Pharmaceuticals, Inc. FY net income USD -102.329 million.

FY operating expenses USD 114.017 million

FY basic EPS USD -1.71